Open-House Biologics Discount Contracts 2024-11 - Hepatitis B Immune Globulin (ATC Code J06BB04)
Original notice title
Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2024-11 - Hepatitis-B-Immunglobulin (ATC-Code J06BB04)
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
40 / 100
Risk factors
No commitment from health insurers to purchase any quantity; actual uptake depends on pharmacy selections.
Subject to dispute resolution via social courts, not procurement chambers; legal uncertainty if classification as publi...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until Oct 2026
- Conclusion of discount contracts for Hepatitis-B immune globulin (ATC J06BB04) with qualified pharmaceutical entrepreneurs
- Open-house procedure with no exclusivity and no negotiation of terms
Show full summary
Open-house procedure by German health insurers (Techniker Krankenkasse, HEK, hkk) to conclude discount contracts for Hepatitis-B immune globulin (ATC J06BB04) under §130a Abs. 8 SGB V. The procedure runs from 01.11.2024 to 31.10.2026, with eligibility for any qualified pharmaceutical entrepreneur meeting authorization and reliability criteria. Contracts are non-exclusive, no negotiations, and participation possible at any time during the term. No estimated value provided.
Risks
No commitment from health insurers to purchase any quantity; actual uptake depends on pharmacy selections.
Subject to dispute resolution via social courts, not procurement chambers; legal uncertainty if classification as publi...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical entrepreneur according to §4 Abs. 18 AMG regarding the offered medicinal product
- Must have a valid marketing authorization under §21 AMG or equivalent right to place on the market
- Must have seat in Germany, EU, or EEA (§9 Abs. 2 AMG)
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (1)
LOT-0001
Open-House Biologics Discount Contracts 2024-11 - Hepatitis B Immune Globulin (ATC Code J06BB04)
Conclusion of discount contracts for Hepatitis-B immune globulin (ATC J06BB04) as an open-house procedure. No exclusivity, no negotiations, uniform conditions.
Location
Duration
Category
Deadline
Award details
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Hepatitis-B-Immunglobulin (ATC-Code J06BB04) im Rahmen eines Open-House-Verfahrens.
Value note
Show original TED data
Original lot title
Open-House-Biologika-Rabattverträge 2024-11 - Hepatitis-B-Immunglobulin (ATC-Code J06BB04)
Original TED description
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Hepatitis-B-Immunglobulin (ATC-Code J06BB04) im Rahmen eines Open-House-Verfahrens.
Procurement Details
- Publication date
- 22 Sep 2024
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 569809-2024
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
40 / 100
Risk factors
No commitment from health insurers to purchase any quantity; actual uptake depends on pharmacy selections.
Subject to dispute resolution via social courts, not procurement chambers; legal uncertainty if classification as publi...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications